Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

International Stem Cell (ISCO) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to $0.0.

  • International Stem Cell's EPS (Basic) rose 12320.0% to $0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.0, marking a year-over-year increase of 10394.56%. This contributed to the annual value of -$0.03 for FY2024, which is 7344.14% up from last year.
  • International Stem Cell's EPS (Basic) amounted to $0.0 in Q3 2025, which was up 12320.0% from $0.01 recorded in Q2 2025.
  • In the past 5 years, International Stem Cell's EPS (Basic) registered a high of $0.03 during Q2 2021, and its lowest value of -$0.08 during Q1 2021.
  • In the last 5 years, International Stem Cell's EPS (Basic) had a median value of -$0.0 in 2023 and averaged -$0.01.
  • Data for International Stem Cell's EPS (Basic) shows a peak YoY increase of 1210600.0% (in 2023) and a maximum YoY decrease of 173571.43% (in 2023) over the last 5 years.
  • Over the past 5 years, International Stem Cell's EPS (Basic) (Quarter) stood at -$0.05 in 2021, then surged by 107.53% to $0.0 in 2022, then crashed by 1735.71% to -$0.06 in 2023, then surged by 102.62% to $0.0 in 2024, then surged by 141.67% to $0.0 in 2025.
  • Its EPS (Basic) stands at $0.0 for Q3 2025, versus $0.01 for Q2 2025 and -$0.03 for Q1 2025.